A randomized trial of methotrexate versus azathioprine for severe atopic eczema Mandy Elvira Schram, MD, Evelien Roekevisch, MD, Mariska Maria Geertruida Leeflang, PhD, Jan Dositheus Bos, MD, PhD, FRCP, Jochen Schmitt, MD, Phyllis Ira Spuls, MD, PhD Journal of Allergy and Clinical Immunology Volume 128, Issue 2, Pages 353-359 (August 2011) DOI: 10.1016/j.jaci.2011.03.024 Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 1 Screening, randomization, treatment, and follow-up of study participants. ∗Data for the per-protocol analysis are not shown. AE, Adverse event. Journal of Allergy and Clinical Immunology 2011 128, 353-359DOI: (10.1016/j.jaci.2011.03.024) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 2 Mean (SD) scores for the SCORAD score at baseline, during treatment, and during follow-up. AZA, Azathioprine; MTX, methotrexate. Journal of Allergy and Clinical Immunology 2011 128, 353-359DOI: (10.1016/j.jaci.2011.03.024) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions